InsidersTradesSigma
Track the Dr. Lal Path Labs Ltd. share price and the full management transaction log of the company, a listed issuer based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Dr. Lal Path Labs Ltd. has logged 877 reports. Market capitalisation: €326.1bn. The latest transaction was filed on 1 May 2026 (Purchase). Among the most active insiders: Dr. Lal PathLabs Employees Welfare Trust. Every trade is free.
877
Insider Decl.
n/a
Thresholds
€12m
355 ops.
Buy Volume
€87m
521 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Dr. Lal Path Labs Ltd. Buy (bullish), based on 26 analysts. Average price target: ₹1,927.85.
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,912 of 29,057 companies
59.5
score / 100
Value32
Quality87
FCF yld1.4%
Earn yld1.6%
EV/EBITDA38.0x
ROE21%
Gross mgn81%
Net mgn18%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 May 2026
Declarations877 total
82,750 shares@ ₹1,141.200.0003% mcap100.0% of flowEquity SharesSEBI:8b012cc53062923f0f2687dce98eef605f9e9f7b
1,000 shares@ ₹1,302.700.0000% mcap0.4% of flowEquity SharesSEBI:e04ed63654c585f52596714c1ecc0e354dfb9599
2,024 shares@ ₹761.85570.1% of flowEquity SharesSEBI:09943fcf986cfecd303497d8702237d004d71541
1,500 shares@ ₹1,026.25075.7% of flowEquity SharesSEBI:fbbdfb416836614c2045b4fde14279f6c6b90cf2
1,876 shares@ ₹357.21320.1% of flowEquity SharesSEBI:3ca758f4a95e8e80365714821d8905de69f0b4d2
2,470 shares@ ₹1,444.9081.3% of flowEquity SharesSEBI:0d764ee1ff035e91e70600a162c85f1244f3235c
4,000 shares@ ₹155.650.2% of flowEquity SharesSEBI:bb6e9970ba4bc5c9e61412678dbbdffc6f09e630
2,500 shares@ ₹1,462.801.2% of flowEquity SharesSEBI:4f736f5a04ffdc28c700aab6002e93065456fef2
2,500 shares@ ₹1,014.00611.5% of flowEquity SharesSEBI:bc09e0ecd4ebc8d1f6043ffb116af6837e5e30ae
424 shares@ ₹5.000.0% of flowEquity SharesSEBI:e40c05b41d2a005c1c9a69a431a75a750b6dd907
250 shares@ ₹10.000.0% of flowEquity SharesSEBI:41923ec0102249f604a2a371b38e826f98f67dc8
1,750 shares@ ₹1,453.009.5% of flowEquity SharesSEBI:af7d6c0111386e0ac314f4271d2e5ad10b4c6d89
4,424 shares@ ₹575.18870.2% of flowEquity SharesSEBI:fe8d3542291268e73082c4d5edbdb0e6518b0f2a
2,500 shares@ ₹10.000.0% of flowEquity SharesSEBI:ae6813ba5062052a6ad289ad8eca4118ad7ce7ff
4,350 shares@ ₹230.69560.1% of flowEquity SharesSEBI:03c18163a15f9074fd5a6990aafca60bc12b3109
450 shares@ ₹10.000.1% of flowEquity SharesSEBI:3923c6bdcf7d84168a978e8a5a587ef9c7aa20a0
750 shares@ ₹10.0011.0% of flowEquity SharesSEBI:8034458aba519b94b4b037c9c9f22d0cb030aaa2
686 shares@ ₹709.72740.0% of flowEquity SharesSEBI:cdea453e786a35f74e4d713d78b28e4d4b8371dc
3,200 shares@ ₹10.000.0% of flowEquity SharesSEBI:ee0faa3b258fd5d5b5093b748dda3e7973f98209
3,200 shares@ ₹10.000.9% of flowEquity SharesSEBI:9998a8c02e4f59f5b27389fa56a33dd7269d79b0
950 shares@ ₹10.0014.4% of flowEquity SharesSEBI:dfd2fea136d8f5c3649a453c14dcffeb9ef53776
1,436 shares@ ₹436.70540.1% of flowEquity SharesSEBI:6a74ab8828f386470d11afc4d084361109327905
5,250 shares@ ₹10.000.1% of flowEquity SharesSEBI:36399c027fb0be145dbad3f2f718af66be196d49
5,750 shares@ ₹10.000.0% of flowEquity SharesSEBI:853c5934e66c33a88f76b8c0b567fe752088081b
3,000 shares@ ₹3,125.76775.5% of flowEquity SharesSEBI:21be029353ef2e4a3ef39fd7f5a390098a678cba
25 of 877 declarations
Acerca de Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. es una empresa india especializada en servicios de diagnóstico médico. Ofrece una amplia gama de pruebas de laboratorio y servicios de salud.